CUSIP: 71426VAK4
What is CUSIP 71426VAK4?
CUSIP 71426VAK4 identifies 71426VAK4 - PERNIX THERAPEUTICS HLDGS IN - DBCV 4.250% 4/0 in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 71426VAK4:
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2019 Q2 | $0 | $0 | -$46,000 | 0 | |
| 2019 Q1 | $4,000,000 | $46,000 | -$3,858,000 | 1.15% | 2 |
| 2018 Q4 | $28,250,000 | $4,158,000 | -$3,355,190 | 10.0% | 7 |
| 2018 Q3 | $69,725,000 | $26,717,000 | 41.7% | 12 | |
| 2018 Q2 | $69,725,000 | $28,834,000 | 43.13% | 12 | |
| 2018 Q1 | $69,725,000 | $30,465,000 | -$2,544,000 | 43.15% | 12 |
| 2017 Q4 | $78,225,000 | $32,222,000 | +$14,000 | 41.5% | 13 |
| 2017 Q3 | $78,225,000 | $32,108,000 | -$13,507,002 | 41.55% | 13 |
| 2017 Q2 | $130,000,000 | $37,109,000 | +$20,157 | 28.25% | 14 |
| 2017 Q1 | $112,000,000 | $30,972,000 | +$529,000 | 27.5% | 11 |
| 2016 Q4 | $128,000,000 | $31,523,000 | -$1,279,370 | 24.65% | 13 |
| 2016 Q3 | $103,990,000 | $29,638,000 | +$775,000 | 28.0% | 13 |
| 2016 Q2 | $128,000,000 | $29,010,000 | +$29,010,000 | 23.0% | 15 |